CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

A Prospective, Multicenter, Randomized, Open-label Trial to Compare Efficacy and Safety of Clopidogrel vs. Ticagrelor in Stabilized Patients with Acute Myocardial Infarction after Percutan eous Coronary Intervention: rationale and design of the TALOS-AMI trial Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial A Controlled Trial of Rivaroxaban After Transcatheter Aortic-Valve Replacement Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation Comparison of Outcomes of Percutaneous Coronary Intervention on Native Coronary Arteries Versus on Saphenous Venous Aorta Coronary Conduits in Patients With Low Left Ventricular Ejection Fraction and Impella Device Implantation Achieved or Attempted (from the PROTECT II Randomized Trial and the cVAD Registry) Valve‐in‐Valve for Degenerated Transcatheter Aortic Valve Replacement Versus Valve‐in‐Valve for Degenerated Surgical Aortic Bioprostheses: A 3‐Center Comparison of Hemodynamic and 1‐Year Outcome

Consensus2010 May;6(1):34-8.

JOURNAL:EuroIntervention. Article Link

Consensus from the 5th European Bifurcation Club meeting

Hildick-Smith D, Lassen JF, Albiero R et al.

Full Text PDF